Tag: GLP-1 drugs

Market News

Eli Lilly Stock Surges on Massive Earnings Beat and Raised Guidance

Eli Lilly just delivered a knockout first quarter that sent shares soaring. But was the earlier selloff really justified, or...

04/05/2026

4 views

Read More

Market News

How GLP-1 Drugs Are Supercharging Hershey Mint and Gum Sales

Weight-loss injections are changing more than waistlines. Hershey just reported a noticeable lift in mint and gum sales tied to...

04/05/2026

7 views

Read More

Market News

Eli Lilly Foundayo Weight Loss Pill Shows Strong Early Momentum

Over 20,000 people jumped on Eli Lilly's new daily weight loss pill in just the first few weeks. The CEO...

03/05/2026

4 views

Read More

Market News

Novo Claims Oral Wegovy Beats New Lilly Pill in Weight Loss

Just as Eli Lilly launches its new oral weight loss pill, Novo Nordisk hits back with data claiming their version...

02/04/2026

4 views

Read More

Market News

GLP-1 Drugs Reshaping Restaurant Menus and Diets

With one in eight Americans now on GLP-1 drugs, restaurants face a major shift: fewer calories, less snacking, smaller meals....

22/03/2026

7 views

Read More

Market News

Stopping GLP-1 Drugs Raises Heart Risks New Study

New study alerts that stopping GLP-1 drugs can undo years of heart protection in just months leading to higher risks...

20/03/2026

1 views

Read More

Market News

Hims & Hers Stock Surges on Novo Nordisk GLP-1 Deal

In a shocking twist, Hims & Hers and Novo Nordisk have ended their bitter GLP-1 battle, paving the way for...

09/03/2026

7 views

Read More

Market News

Novo And Hims End Feud: Wegovy Partnership Boost

The long-running battle between a major pharma giant and a popular telehealth player over blockbuster weight-loss drugs has suddenly flipped—ending...

08/03/2026

2 views

Read More

Market News

US Dominates Weight-Loss Injection Boom

The US accounts for over 60% of global weight-loss injection sales, with usage soaring as obesity dips slightly. But what...

06/03/2026

3 views

Read More

Market News

Novo Nordisk Struggles: GLP-1 Market Challenges 2026

Novo Nordisk's stock has crashed 75% from its peak amid fierce competition, pricing squeezes, and a disappointing pipeline trial. Is...

26/02/2026

9 views

Read More